Sanofi Names Brian Foard Head of Specialty-Care Unit
09 Janvier 2024 - 8:14AM
Dow Jones News
By Adria Calatayud
Sanofi appointed Brian Foard, who has helmed the launch of its
blockbuster anti-inflammatory drug Dupixent, as permanent head of
its specialty-care business unit and member of its executive
committee.
Foard, who has more than 20 years of experience in the industry,
has been interim head of the unit since September while also
serving as head of specialty care in North America and U.S. country
lead, the French pharmaceutical company said Tuesday.
He joined the company in 2017 and began his career with
Galderma, Sanofi said.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
January 09, 2024 01:59 ET (06:59 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Sanofi (EU:SAN)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
